| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analyzing diagnostic and treatment wait times for lung cancer Patients: Key insights from a provincial registry study
|
Blanco-Villar, Manuel Luis
|
|
|
194 |
C |
p.
|
artikel
|
| 2 |
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
|
Kim, Yu Jung
|
|
|
194 |
C |
p.
|
artikel
|
| 3 |
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study)
|
Jacob, Mathilde
|
|
|
194 |
C |
p.
|
artikel
|
| 4 |
Asbestos-Related lung Cancer: An underappreciated oncological issue
|
van Zandwijk, Nico
|
|
|
194 |
C |
p.
|
artikel
|
| 5 |
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC
|
Provencio, Mariano
|
|
|
194 |
C |
p.
|
artikel
|
| 6 |
Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinoma
|
Ogawa, Hiroyuki
|
|
|
194 |
C |
p.
|
artikel
|
| 7 |
Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis
|
Li, Rongzhen
|
|
|
194 |
C |
p.
|
artikel
|
| 8 |
Comparison of the variability and diagnostic efficacy of respiratory-gated PET/CT based radiomics features with ungated PET/CT in lung lesions
|
Huang, Shengyun
|
|
|
194 |
C |
p.
|
artikel
|
| 9 |
Contents
|
|
|
|
194 |
C |
p.
|
artikel
|
| 10 |
CT-guided needle biopsy is not associated with increased ipsilateral pleural metastasis
|
Niedermaier, Benedikt
|
|
|
194 |
C |
p.
|
artikel
|
| 11 |
Effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules
|
Wang, Qingfeng
|
|
|
194 |
C |
p.
|
artikel
|
| 12 |
EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report
|
Yoshizaki, Chinatsu
|
|
|
194 |
C |
p.
|
artikel
|
| 13 |
Environmental asbestos exposure and lung cancer
|
Metintas, Muzaffer
|
|
|
194 |
C |
p.
|
artikel
|
| 14 |
First-line doublet immunotherapy: Game changer or hype for patients with mesothelioma?
|
Douma, L.H.
|
|
|
194 |
C |
p.
|
artikel
|
| 15 |
Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC
|
Xu, Yingqi
|
|
|
194 |
C |
p.
|
artikel
|
| 16 |
Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities
|
Bum Lee, Jii
|
|
|
194 |
C |
p.
|
artikel
|
| 17 |
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
|
Zheng, Qian
|
|
|
194 |
C |
p.
|
artikel
|
| 18 |
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)
|
Fujimoto, Daichi
|
|
|
194 |
C |
p.
|
artikel
|
| 19 |
Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study
|
Arrieta, Oscar
|
|
|
194 |
C |
p.
|
artikel
|
| 20 |
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation
|
Belluomini, Lorenzo
|
|
|
194 |
C |
p.
|
artikel
|
| 21 |
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial
|
Bylicki, Olivier
|
|
|
194 |
C |
p.
|
artikel
|
| 22 |
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
|
Asao, Tetsuhiko
|
|
|
194 |
C |
p.
|
artikel
|
| 23 |
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project
|
Speel, Ernst-Jan M.
|
|
|
194 |
C |
p.
|
artikel
|
| 24 |
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study
|
Pons-Tostivint, Elvire
|
|
|
194 |
C |
p.
|
artikel
|
| 25 |
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer
|
Izumi, Motohiro
|
|
|
194 |
C |
p.
|
artikel
|
| 26 |
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
|
Oya, Yuko
|
|
|
194 |
C |
p.
|
artikel
|
| 27 |
Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC
|
Gallina, Filippo Tommaso
|
|
|
194 |
C |
p.
|
artikel
|
| 28 |
Treatment patterns and outcomes in KRASG12C ‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study
|
Barghout, Samir H.
|
|
|
194 |
C |
p.
|
artikel
|
| 29 |
Treatment sequences in EGFR mutant advanced NSCLC
|
Wespiser, M.
|
|
|
194 |
C |
p.
|
artikel
|
Tijdschrift beschrijving